Hidaytulla Aga

Title: Hidaytulla Aga: Innovator in Pharmaceutical Formulations

Introduction

Hidaytulla Aga is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications that enhance bioavailability. His work is characterized by a commitment to improving patient outcomes through innovative drug delivery systems.

Latest Patents

Hidaytulla Aga holds a patent for a pharmaceutical formulation of cefixime designed for enhanced bioavailability. This invention is a chewable tablet comprising cefixime with a mean particle size between 20μ and 120μ. The composition demonstrates bioequivalence to a suspension of cefixime trihydrate. The preparation process involves several steps, including optional micronization of cefixime, blending with excipients, roll compaction, milling to form granules, and compression to create tablets. This innovative approach aims to improve the effectiveness of cefixime in treating infections.

Career Highlights

Hidaytulla Aga is currently associated with Lupin, Inc., a leading global pharmaceutical company. His role involves research and development, focusing on creating formulations that meet the needs of patients and healthcare providers. His dedication to innovation has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Hidaytulla has collaborated with several professionals in his field, including Sanjay Chhagan Wagh and Makarand Krishnakumar Avachat. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.

Conclusion

Hidaytulla Aga's contributions to pharmaceutical formulations exemplify the impact of innovation in healthcare. His work not only enhances the bioavailability of essential medications but also reflects a broader commitment to improving patient care.